Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck other (Income) Expense Breakdown — Net Periodic Defined Benefit Plan (Credit) Cost ($M) ($M)
Form 8-K Table 4
Latest, FY2025
-615
Period ended Dec 31, 2025
Change on a year earlier
-2.8%
-633 in FY2024
History
7 years
Since FY2017
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other (Income) Expense Breakdown — Net Periodic Defined Benefit Plan (Credit) Cost ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -615 | -2.8% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | -633 | +27.1% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | -498 | +78.5% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | -279 | – | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2019 | Dec 31, 2019 | -545 | +6.4% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2018 | Dec 31, 2018 | -512 | 0.0% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2017 | Dec 31, 2017 | -512 | – | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
Cite this data
StockData. (2026). Merck Other (Income) Expense Breakdown — Net Periodic Defined Benefit Plan (Credit) Cost ($M) ($M), annual FY2017–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/other_inc_exp_db_credit
See every metric in the Merck KPI table. Data updated Oct 26, 2026.